摘要
糖皮质激素诱导的TNFR家族相关受体(GITR),也被称为TNFRSF18、AITR(人类)。静止T细胞低水平表达GITR,而CD4^+CD25^+调节性T细胞则呈高水平表达。GITR与其配体(GITRL)结合后会增强T细胞激活、增殖、分泌细胞因子、MAPKs和NF-κB激活效应、抑制CD4^+CD25^+Treg细胞的功能,从而加强效应性T细胞的活性,有利于增强抗肿瘤免疫和抗病毒免疫。随着生物学环境的变化,GITR激活Siva或者TRAF,起着促进或诱导凋亡的作用。
Glucocorticoid-induced TNFR-related receptor (GITR) is also known as TNFRSF18 or AITR (human). GITR is expressed at low levels in resting T lymphocytes and up-regulated in CD4 ^+ CD25^+ regulatory T cells (Treg). The combination of GITR and its ligand (GITRL) will promote the activation, proliferation, and cytokine secretion of T cells, the activation of MAPKs and NF-κB, and the inhibition of CD4 ^+ CD25 ^+ Treg cells. This will increase the activation of effector T cells and improve the anti-tumor and antiviral immunity. Depending upon the microenviromnent, GITR can activate Siva to promote apoptosis or TRAF to induce apoptosis.
出处
《国际免疫学杂志》
CAS
2007年第3期171-174,共4页
International Journal of Immunology